Opus Genetics, Inc. (FRA:R3X1)
Germany flag Germany · Delayed Price · Currency is EUR
2.350
+0.015 (0.64%)
Last updated: Jan 28, 2026, 5:00 PM CET

Opus Genetics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1343662695758
Market Cap Growth
273.54%-41.14%-10.30%21.12%-1.36%-
Enterprise Value
109123563765
Last Close Price
1.911.092.792.943.204.76
PE Ratio
---4.11--
PS Ratio
10.753.423.581.84109.56-
PB Ratio
26.371.471.371.592.90-5.22
P/TBV Ratio
26.375.591.371.592.90-
P/FCF Ratio
---5.13--
P/OCF Ratio
---5.13--
EV/Sales Ratio
8.850.091.351.4971.13-
EV/EBITDA Ratio
---3.26--
EV/EBIT Ratio
---3.26--
EV/FCF Ratio
---4.16--
Debt / Equity Ratio
0.18---0.02-
Asset Turnover
0.380.240.371.060.03-
Quick Ratio
1.213.2013.0817.276.425.15
Current Ratio
1.243.2413.3517.796.765.55
Return on Equity (ROE)
-338.75%-152.46%-20.77%52.26%-1295.10%-
Return on Assets (ROA)
-60.73%-46.90%-12.83%30.35%-64.86%-60.78%
Return on Invested Capital (ROIC)
---717.11%2291.84%--
Return on Capital Employed (ROCE)
-528.40%-133.30%-21.20%39.40%-102.20%-65.30%
Earnings Yield
-43.35%-153.15%-14.66%24.35%-87.85%-34.99%
FCF Yield
--68.08%-1.63%19.49%-30.17%-11.76%
Buyback Yield / Dilution
-99.64%-23.74%-4.82%-38.68%-218.65%-63.84%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.